Antibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Western blot [1]
- ELISA [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- RA0018 - Provider product page

- Provider
- Oursmab
- Product name
- Dezamizumab (Biosimilar Reference Antibody) (APCS)
- Antibody type
- Monoclonal
- Description
- Dezamizumab (GSK 2398852) is a fully humanized recombinant monoclonal IgG1 antibody specifically targeting the serum amyloid P component (SAP). It was developed as a potential therapy for systemic amyloidosis, a group of diseases characterized by the deposition of misfolded protein fibrils (amyloid) in organs and tissues. The antibody's mechanism was designed to bind to SAP, a universal constituent of amyloid deposits, and promote their clearance by the immune system. Despite reaching clinical trials, the development of dezamizumab for amyloidosis was ultimately discontinued due to an unfavorable benefit-risk assessment, including insufficient efficacy in clearing amyloid from critical organs like the heart.
- Reactivity
- Human
- Isotype
- IgG
- Vial size
- 100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg
- Concentration
- Bottled at the concentration indicated on the vial.
- Storage
- Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.
No comments: Submit comment
Supportive validation
- Submitted by
- Oursmab (provider)
- Main image

- Experimental details
- Dezamizumab (Biosimilar Reference Antibody) (APCS)-RA0018-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.
Supportive validation
- Submitted by
- Oursmab (provider)
- Main image

- Experimental details
- ELISA plate pre-coated Antigen protein, can bind Dezamizumab (Biosimilar Reference Antibody) (APCS)-RA0018 in a linear range of 3.91-125 ng/mL.